Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taro Calcipotriene/Betamethasone vs Taclonex in Scalp Psoriasis
NCT03880357Phase 1Completed
- Start
- Oct 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of calcipotriol + betamethasone in psoriasis (3 arms). Primary endpoints: Treatment success on the Physician's Global Assessment at Week 4 and Clinical success on the Psoriasis Area and Severity Index (PASI) at Week 4. Started Oct 2018; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT03880357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03880357.